634 related articles for article (PubMed ID: 8710158)
1. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
[TBL] [Abstract][Full Text] [Related]
2. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?
Braun J; Hammerschmidt M; Schreiber M; Heidler R; Hörl WH
Nephrol Dial Transplant; 1996 Mar; 11(3):492-7. PubMed ID: 8671820
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
[TBL] [Abstract][Full Text] [Related]
4. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
Matuszkiewicz-Rowińska J; Ostrowski G; Niemczyk S; Przedlacki J; Wardyn K; Puka J; Włodarczyk D; Switalski M; Zakrzewska T; Ostrowski K
Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
[TBL] [Abstract][Full Text] [Related]
5. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients.
Fishbane S; Lynn RI
Am J Kidney Dis; 1995 Mar; 25(3):426-32. PubMed ID: 7872320
[TBL] [Abstract][Full Text] [Related]
6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
7. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
[TBL] [Abstract][Full Text] [Related]
8. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency.
Rettmer RL; Carlson TH; Origenes ML; Jack RM; Labb RF
Pediatrics; 1999 Sep; 104(3):e37. PubMed ID: 10469820
[TBL] [Abstract][Full Text] [Related]
9. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome.
Matzkies FK; Cullen P; Schaefer L; Hartmann M; Hohage H; Schaefer RM
South Med J; 1999 Dec; 92(12):1157-61. PubMed ID: 10624905
[TBL] [Abstract][Full Text] [Related]
10. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
12. Iron supplementation in haemodialysis--practical clinical guidelines.
Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
[TBL] [Abstract][Full Text] [Related]
13. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
14. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
15. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.
Tessitore N; Solero GP; Lippi G; Bassi A; Faccini GB; Bedogna V; Gammaro L; Brocco G; Restivo G; Bernich P; Lupo A; Maschio G
Nephrol Dial Transplant; 2001 Jul; 16(7):1416-23. PubMed ID: 11427634
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
Kim JM; Ihm CH; Kim HJ
Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
[TBL] [Abstract][Full Text] [Related]
17. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
[TBL] [Abstract][Full Text] [Related]
18. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
19. Central role of zinc protoporphyrin in staging iron deficiency.
Hastka J; Lasserre JJ; Schwarzbeck A; Hehlmann R
Clin Chem; 1994 May; 40(5):768-73. PubMed ID: 8174250
[TBL] [Abstract][Full Text] [Related]
20. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
Tsuchiya K; Okano H; Teramura M; Iwamoto Y; Yamashita N; Suda A; Shimada K; Nihei H; Ando M
Clin Nephrol; 2003 Feb; 59(2):115-23. PubMed ID: 12608554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
